Cover Image

Criteria to identify patients with atopic dermatitis in the National Health Insurance data in Korea

Saved in:

Bibliographic Details
Main Authors:	Hyejung Jung, MD (Author), Jaein Lee, MD (Author), Donghyek Jang, MD (Author), Miyoun Park, MD, PhD (Author), Jiyoung Ahn, MD, PhD (Author)
Format:	Book
Published:	Elsevier, 2020-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between chronic pruritus, depression, and insomnia: A cross-sectional studyCapsule Summary
by: Jaein Lee, MD, et al.
Published: (2021)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021)

Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine
by: Rasool Choopani MD, PhD, et al.
Published: (2017)

Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine
by: Rasool Choopani MD, PhD, et al.
Published: (2017)

A case series of acne following Janus kinase inhibitors in patients with atopic dermatitis
by: Sang-Doo Lee, MD, et al.
Published: (2022)

Severe atopic dermatitis with cutis laxa caused by a variant in the ELN gene
by: Tatsuya Katsumi, MD, et al.
Published: (2024)

Accuracy and efficiency of telemedicine in atopic dermatitisCapsule Summary
by: Mara Giavina-Bianchi, MD, PhD, et al.
Published: (2020)

Association of the Magnitude of Nurses With the Use of Health Information Exchanges: Analyzing the National Health Insurance Claim Data of Hospitals and Clinics in Korea
by: Young-Taek Park PhD, et al.
Published: (2021)

Release of cervical muscular tension improved severe pruritus in moderate-to-severe atopic dermatitis: A case series
by: Shusaku Hosono, MD, et al.
Published: (2020)

Effects of disease severity on sleep and quality of life in Taiwanese patients with atopic dermatitis
by: Pei-Yun Ho, MD, et al.
Published: (2022)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
by: Danielle M. Peterson, MD, et al.
Published: (2021)

Introduction of self-injection increases compliance with dupilumab administration in adult patients with atopic dermatitis: A single-center retrospective study
by: Makoto Ito, MD, et al.
Published: (2020)

A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
by: Jiahui Zhao, PhD, MD, et al.
Published: (2022)

Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry
by: Jonathan I. Silverberg, MD, PhD, MPH, et al.
Published: (2024)

Correlation between anxiety and depression risk and atopic dermatitis severity in Taiwan: A cross-sectional studyCapsule Summary
by: Chia-Jung Hsu, MD, et al.
Published: (2022)

Drug-induced interstitial lung disease associated with dupilumab for the treatment of atopic dermatitis
by: Bethany F. Wilken, MSc, et al.
Published: (2024)

Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesCapsule Summary
by: Angela L. Bosma, MD, et al.
Published: (2023)

Food allergy testing in atopic dermatitisCapsule Summary
by: Hassiel A. Ramírez-Marín, MD, et al.
Published: (2022)

The fetal/placental weight ratio is associated with the incidence of atopic dermatitis in female infants during the first 14 months: The Hamamatsu Birth Cohort for Mothers and Children (HBC Study)
by: Masako Matsumoto, MD, et al.
Published: (2020)

Safety Profile and Tolerability of Topical Phosphodiesterase 4 Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
by: Ana Martín-Santiago, MD, et al.
Published: (2022)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023)

Characterization of atopic dermatitis in older adults: A retrospective study
by: Hannah Y. Wang, BS, et al.
Published: (2024)

Prevalence of baseline comorbidities in patients with atopic dermatitis: A population-based cohort study in TaiwanCapsule Summary
by: Yung-Tsu Cho, MD, et al.
Published: (2020)

Phenotypic differences of atopic dermatitis stratified by ageCapsule Summary
by: Sheena Chatrath, BA, et al.
Published: (2023)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Association between early life antibiotic exposure and development of early childhood atopic dermatitisCapsule Summary
by: Jennifer J. Schoch, MD, et al.
Published: (2023)

Atopic dermatitis is associated with hidradenitis suppurativa diagnosis: A single institution retrospective cohort studyCapsule Summary
by: Rayan N. Kaakati, MD, et al.
Published: (2021)

Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort
by: Stine Elsgaard, MBBS, et al.
Published: (2021)

Recent updates on systemic treatment of atopic dermatitis
by: Jiyoung Ahn
Published: (2024)

Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilCapsule Summary
by: Lawrence F. Eichenfield, MD, et al.
Published: (2021)

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysisCapsule Summary
by: Norito Katoh, MD, PhD, et al.
Published: (2022)

A feasibility study of the burden of disease of atopic dermatitis using a smartphone research application, myEczema
by: Sheevam Shah, MD, et al.
Published: (2020)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
by: Jonathan J. Park, PhD, et al.
Published: (2023)

Dupilumab improved atopic dermatitis without aggravating tuberculous eosinophilic pleural effusion in hyperimmunoglobulin-E syndrome
by: Piyaporn Chokevittaya, MD, et al.
Published: (2024)

Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE
by: Melinda J. Gooderham, MSc, MD, FRCPC, et al.
Published: (2021)

Remote severity assessment in atopic dermatitis: Validity and reliability of the remote Eczema Area and Severity Index and Self-Administered Eczema Area and Severity IndexCapsule Summary
by: Aviël Ragamin, MD, et al.
Published: (2023)

Asymptomatic Early-Stage Encapsulating Peritoneal Sclerosis Identified Laparoscopically
by: Yoko Shirai, MD, PhD, et al.
Published: (2024)

Environmental and behavioral mitigation strategies for patients with atopic dermatitisCapsule Summary
by: Nadia Shobnam, MD, et al.
Published: (2024)

Livedoid Dermatitis Treated With Nifedipine
by: Lee Wheless MD, PhD, et al.
Published: (2016)

Chronic actinic dermatitis as a diagnostic clue for adult T-cell leukemia/lymphoma
by: Sakiho Inayoshi, MD, et al.
Published: (2025)